Agricultural biotech market seen reaching $268.9 billion by 2034

By AI, Created 10:58 AM UTC, May 18, 2026, /AGP/ – The agricultural biotechnology market was valued at $159.2 billion in 2025 and is projected to grow to $268.9 billion by 2034, driven by gene editing, sustainability pressures and food-security concerns. North America leads today, while Asia Pacific is expected to post the fastest growth.

Why it matters: - Agricultural biotechnology is moving from niche science to a core part of global food production. - The market’s growth is tied to rising food demand, climate stress, shrinking farmland and water constraints. - Companies that can turn gene editing, biologicals and digital agriculture into commercial products are positioned to capture outsized value.

What happened: - The global agricultural biotechnology market was valued at USD 159.2 billion in 2025. - The market is projected to reach USD 268.9 billion by 2034. - The forecast implies a compound annual growth rate of 5.81% from 2026 to 2034. - A sample report is available here. - A report consultation page is available here.

The details: - Demand is being driven by the need to produce more food with fewer inputs. - Biotech-enabled crops can help raise yields, improve pest resistance, and increase climate resilience. - CRISPR and other gene-editing tools are shortening development timelines for new plant varieties. - Gene editing allows targeted changes to plant genomes faster than conventional breeding. - The Kal91.3 potato, developed by Michigan State University, has lower storage temperatures and better potato chip quality. - The U.S. Department of Agriculture exempted the Kal91.3 potato from biotechnology regulation, simplifying its path to market. - Sustainability and regenerative agriculture pressures are pushing companies to invest in soil health, carbon sequestration and reduced chemical inputs. - ADM and Smucker announced a July 2024 partnership to advance regenerative agriculture practices on 20,000 acres per year of peanuts grown in the United States. - India has introduced Digital Public Infrastructure in agriculture, with Rs 1.52 lakh crore set aside for agriculture and allied sectors.

Between the lines: - The market is being shaped by a shift from broad genetic modification debates to more targeted views on gene editing. - Regulatory acceptance of gene-edited products is emerging faster than acceptance of traditional GMOs in some markets. - The biggest commercial opportunities appear to be in plants, synthetic biology and genome editing. - North America’s lead reflects strong R&D, major industry players and comparatively favorable regulation. - Asia Pacific is the fastest-growing region, supported by government programs and food-security priorities. - Europe’s stricter GMO rules are steering demand toward biofertilizers, biopesticides and precision breeding. - Latin America is benefiting from large agricultural acreage and favorable growing conditions. - The Middle East and Africa remain early-stage markets, but food-security needs are creating long-term potential. - Major players are competing on integrated platforms, not just seeds or traits. - Bayer plans to launch 10 blockbuster products over the next decade, each targeting more than EUR 500 million in revenue, while aiming to scale regenerative agriculture across 400 million acres globally. - BASF plans to invest a high double-digit million euro amount in a new fermentation plant at Ludwigshafen for biological crop protection products starting in the second half of 2025. - Syngenta opened selected genome-editing and breeding technologies for global academic research through its Shoots by Syngenta platform in June 2024. - Corteva is using CRISPR-Cas, data science, genomics, AI and machine learning through its CropOS platform to speed crop trait development.

What’s next: - Growth is expected to continue as companies commercialize gene-edited crops, biological crop protection and regenerative agriculture tools. - Regulatory clarity for gene-edited products could speed adoption in more markets. - AI-driven research and development may lower costs and shorten timelines for new biotech traits. - Firms with strong regulatory strategy, digital capabilities and farmer-facing services are likely to gain share.

The bottom line: - Agricultural biotechnology is becoming a mainstream growth market, and the biggest winners will be the companies that can convert scientific advances into scalable products across seeds, biologicals and precision agriculture.